Sellas Stock 346% Year Near Final REGAL Deaths Ahead
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Zero Based Budgeting simplifies money management by requiring deliberate allocations, helping you stay on track with objectives and deadlines.
24,545 articlesSellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
A hypothetical retiree with $4.6 million must choose how to gift $125,000 without triggering a heavy tax bill. Clark ...
A late-stage private AI company is inviting retail buyers to participate in a sub-$1 pre-IPO round, with shares at $0...
Micron shares slid about 4% in early trading even after the company posted a robust quarterly report and raised its f...
JPMorgan's revised target to $134 underscores a brighter backdrop for Bunge as the Viterra deal closes and 2026 biofu...
Micron Technology posted a strong quarter but faced a sharp pullback as investors priced in a tougher near-term path....
What would it look like if a legendary duo concentrated nearly $80 billion into one stock? This thought-provoking pie...
Century 21 Chief Executive Mike Miedler says recruiting more Latino agents is crucial to serving the majority of futu...
Beaten-down stocks often hide big upside. Explore a practical, evidence-based approach to identifying a candidate tha...
JPMorgan downgraded Wix.com to Underweight and cut its price target to $91, citing slower core growth and volatile ma...
After a sharp early-2026 retreat, Shopify looks set to re-rate as cash flow strengthens, a new buyback supports the s...
Bitcoin trades near $81,000 as a decisive 72-hour window begins for the crypto market. Traders weigh ETF inflows, liq...